Technical and clinical validation of an environmental exposure unit for ragweed

DSpace/Manakin Repository

Technical and clinical validation of an environmental exposure unit for ragweed

Citable link to this page

 

 
Title: Technical and clinical validation of an environmental exposure unit for ragweed
Author: Gomes, Paul J; Lane, Keith J; Angjeli, Endri; Stein, Linda; Abelson, Mark B

Note: Order does not necessarily reflect citation order of authors.

Citation: Gomes, Paul J, Keith J Lane, Endri Angjeli, Linda Stein, and Mark B Abelson. 2016. “Technical and clinical validation of an environmental exposure unit for ragweed.” Journal of Asthma and Allergy 9 (1): 215-221. doi:10.2147/JAA.S123547. http://dx.doi.org/10.2147/JAA.S123547.
Full Text & Related Files:
Abstract: Background: Allergic rhinitis is a common condition, with ragweed pollen one of the more prevalent aeroallergens. Environmental exposure units such as the Allergen BioCube® are valuable models for clinical allergy studies. A study was conducted to validate the Allergen BioCube for uniform ragweed pollen concentrations and clinically relevant sign and symptom responses to ragweed exposure. Methods: Ragweed pollen concentrations were measured on 3 consecutive days in the Allergen BioCube and verified by Rotorod collection and continuous laser particle count measurements. Subjects (N=10) were exposed to ragweed pollen in the BioCube for 3 hours per day for 3 consecutive days. Subjects assessed their nasal itching, sneezing, rhinorrhea, and nasal congestion during each BioCube exposure; total nasal symptom score was computed. Peak nasal inspiratory flow was also assessed during BioCube exposure. Results: Uniform ragweed pollen concentrations were obtained throughout each of the 3-hour testing periods in the Allergen BioCube, both spatially and temporally, at all subject positions, with a low mean standard deviation of 10%. Pronounced increases in mean total nasal symptom scores (6.7±0.94 to 7.6±0.86, last 90 minutes of exposure) occurred for all three BioCube ragweed pollen exposure visits. Mean peak nasal inspiratory flow decreased 24% at 3 hours of BioCube exposure on Day 3. No safety issues of concern occurred in this study. Conclusion: The Allergen BioCube achieved technical and clinical validation for ragweed allergen. Ragweed pollen concentration was uniform both temporally and spatially. Allergic rhinitis signs and symptoms were induced in subjects during exposure to ragweed in the BioCube at clinically meaningful levels for allergy studies.
Published Version: doi:10.2147/JAA.S123547
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5167464/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:29738953
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters